See every side of every news story
Published loading...Updated

What to Know About Ketamine for Treatment-Resistant Depression

Earlier this year, the Food and Drug Administration (FDA) expanded its approval of Spravato, a ketamine-derived nasal spray originally approved to treat treatment-resistant depression (TRD) when taken alongside an oral antidepressant. This expansion means that patients with TRD can now use it as a standalone treatment when their condition doesn't improve with antidepressants. While ketamine is highly effective at relieving the symptoms of depres…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Earlier this year, the Food and Drug Administration (FDA) expanded its approval of Spravato, a ketamine-derived nasal spray originally approved to treat treatment-resistant depression (TRD) when taken alongside an oral antidepressant. This expansion means that patients with TRD can now use it as a standalone treatment when their condition doesn't improve with antidepressants. While ketamine is highly effective at relieving the symptoms of depres…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

publicgoodnews.com broke the news in on Wednesday, June 25, 2025.
Sources are mostly out of (0)